nifedipine has been researched along with carbamates in 8 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (12.50) | 18.7374 |
1990's | 6 (75.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (12.50) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Ito, K; Nishimura, K; Ota, M | 1 |
Czartolomna, J; Voelkel, NF | 1 |
Chuang, DM; Costa, E; Nakaki, T; Roth, BL | 1 |
Stolc, S | 1 |
Clark, AH; Garland, CJ | 1 |
Leng, L; O'Neil, RG | 1 |
Fujiwara, K; Hayashi, K; Kanno, Y; Nagahama, T; Ohno, Y; Saruta, T; Suzuki, H; Takenaka, T | 1 |
Choi, DH; Choi, I; Choi, JS | 1 |
8 other study(ies) available for nifedipine and carbamates
Article | Year |
---|---|
Existence of two components in the tonic contraction of rat aorta mediated by alpha 1-adrenoceptor activation.
Topics: 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine; Adrenergic alpha-Agonists; Animals; Aorta, Thoracic; Benzopyrans; Calcium; Calcium Channel Blockers; Calcium Radioisotopes; Carbamates; Cromakalim; In Vitro Techniques; Isoquinolines; Lanthanum; Male; Muscle Contraction; Muscle Tonus; Muscle, Smooth, Vascular; Nifedipine; Phenylcarbamates; Phenylephrine; Phosphatidylinositols; Piperazines; Protease Inhibitors; Pyrroles; Rats | 1991 |
Vanadate potentiates hypoxic pulmonary vasoconstriction.
Topics: Animals; Blood Pressure; Carbamates; Catalase; Cyanides; Hypoxia; Lung; Male; Nifedipine; Oxygen; Perfusion; Phenylcarbamates; Pulmonary Artery; Rats; Rats, Inbred Strains; Superoxide Dismutase; Tetradecanoylphorbol Acetate; Vanadates; Vasoconstriction | 1991 |
Phasic and tonic components in 5-HT2 receptor-mediated rat aorta contraction: participation of Ca++ channels and phospholipase C.
Topics: Animals; Aorta; Calcium; Carbamates; Hydrolysis; In Vitro Techniques; Ion Channels; Male; Nifedipine; Phenylcarbamates; Phosphatidylinositols; Phospholipases; Rats; Rats, Inbred Strains; Receptors, Serotonin; Type C Phospholipases; Vasoconstriction | 1985 |
Inhibition of ion currents in membrane of sensory neuron by the antiarrhythmic drug BK 129 and selected Ca2+ entry blockers.
Topics: Animals; Anti-Arrhythmia Agents; Azepines; Calcium Channel Blockers; Carbamates; Ganglia, Spinal; Membrane Potentials; Neurons, Afferent; Nifedipine; Piperidines; Rats; Verapamil | 1993 |
Ca2+ channel antagonists and inhibition of protein kinase C each block contraction but not depolarization to 5-hydroxytryptamine in the rabbit basilar artery.
Topics: 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine; Animals; Basilar Artery; Calcium Channel Blockers; Carbamates; Female; Isoquinolines; Male; Membrane Potentials; Muscle Contraction; Muscle, Smooth, Vascular; Nifedipine; Phenylcarbamates; Piperazines; Potassium; Protein Kinase C; Rabbits; Serotonin; Type C Phospholipases; Verapamil | 1993 |
Osmo-mechanically sensitive phosphatidylinositol signaling regulates a Ca2+ influx channel in renal epithelial cells.
Topics: Animals; Calcium; Calcium Channel Blockers; Calcium Channels; Calcium Channels, L-Type; Carbamates; Cells, Cultured; Dihydropyridines; Enzyme Inhibitors; Epithelium; In Vitro Techniques; Kidney Cortex; Kinetics; Male; Nifedipine; Phenylcarbamates; Phosphatidylinositols; Rabbits; Signal Transduction; Staurosporine; Tetradecanoylphorbol Acetate; Water-Electrolyte Balance | 1997 |
Cellular mechanisms mediating rat renal microvascular constriction by angiotensin II.
Topics: Angiotensin II; Animals; Arterioles; Calcium; Calcium Channel Blockers; Calcium Channels; Carbamates; Ethylmaleimide; GTP-Binding Proteins; In Vitro Techniques; Kidney; Male; Nephrosis; Nifedipine; Perfusion; Phenylcarbamates; Rats; Rats, Sprague-Dawley; Signal Transduction; Thapsigargin; Type C Phospholipases; Vasoconstriction | 1997 |
Effects of nifedipine on the pharmacokinetics of repaglinide in rats: possible role of CYP3A4 and P-glycoprotein inhibition by nifedipine.
Topics: Administration, Oral; Animals; Area Under Curve; ATP Binding Cassette Transporter, Subfamily B, Member 1; Biological Availability; Biomarkers; Biotransformation; Blood Glucose; Calcium Channel Blockers; Carbamates; Cytochrome P-450 CYP3A; Cytochrome P-450 CYP3A Inhibitors; Dose-Response Relationship, Drug; Drug Interactions; Enzyme Inhibitors; Humans; Hypoglycemic Agents; Injections, Intravenous; Male; Nifedipine; Piperidines; Polypharmacy; Rats; Rats, Sprague-Dawley | 2013 |